Real-World Questions Are Crucial To Comparative Effectiveness Research
This article was originally published in The Tan Sheet
Executive Summary
To maximize new funding for research on the comparative effectiveness of health care products and services, research needs to go in new directions and answer real-world questions, former Centers for Medicare and Medicaid Services officials say
You may also be interested in...
Comparative Effectiveness Language Clarified In Compromise Stimulus Bill
Congress took steps in its final version of the economic stimulus package to alleviate concerns that the comparative effectiveness research provisions will lead to the government making cost-based comparisons or making coverage and reimbursement decisions based on the research
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Deal Watch: Sanofi, Boehringer Swap Side Businesses
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.